Mary A. Kosir

Histopathologic evidence of tumor regression in the axillary lymph nodes of patients treated with preoperative chemotherapy correlates with breast cancer outcome.

Improving surgical outcomes: standardizing the reporting of incidence and severity of acute lymphedema after sentinel lymph node biopsy and axillary lymph node dissection.

Challenging paradigms: long non-coding RNAs in breast ductal carcinoma in situ (DCIS).